Chinese labs in Wuhan purchased an increased quantity of coronavirus testing equipment several months before the first virus case was reported to the World Health Organization (WHO) in December 2019, according to a new report.
New data procured by the Australian-U.S. cyber security firm Internet 2.0 found that there was a buy-up of polymerase chain reaction testing equipment (PCR) by nearly 50 percent throughout 2019. PCR tests are widely used to determine if an individual is infected with COVID-19 as it allows scientists to amplify DNA samples to check for disease or other genetic material.
According to the new findings, in 2019, there were 135 contracts containing PCR equipment issued by Wuhan laboratories, up from 89 in 2018 and 72 in 2017. Furthermore, financial investment on PCR equipment increased by nearly 600 percent from 2015 to 2019 in Wuhan, The Australian reported.